Curated for Orthogate.org Members

EXECUTIVE SUMMARY

• OrthAlign Surpasses 500,000 Joint Replacement Procedures Worldwide: Reported by OrthoSpineNews, OrthAlign celebrated over 500,000 joint replacement procedures performed across more than twenty countries with its Lantern® handheld navigation platform, validating open-platform handheld navigation as an accurate, cost-effective alternative to capital-intensive robotic consoles in hospital ORs and ASCs.
• Catalyst OrthoScience Joins Redefine Surgery as Founding Partner in Shoulder Arthroplasty Intelligence: Announced via OrthoSpineNews, Catalyst OrthoScience partnered with Redefine Surgery to develop an integrated shoulder arthroplasty surgical intelligence ecosystem spanning 3D planning, intraoperative guidance, and analytics targeting up to 4x procedural efficiency at substantially lower technology cost.
• SIGNUS USA Marks American Debut with First U.S. Implantation of the COSY OCT Spine Fixation System: Reported by OrthoSpineNews, SIGNUS USA achieved its first U.S. clinical implantation of the COSY posterior occipito-cervico-thoracic system, offering modular screw angulation up to 70 degrees and dedicated transition rods integrating with the DIPLOMAT® platform.
• Massachusetts General Hospital GSPE Spacer Cleared: The General Hospital Corporation, d/b/a Massachusetts secured FDA 510(k) clearance (K260063) for its GSPE Spacer indicated as an ultra-high-molecular-weight polyethylene tibial spacer in total knee arthroplasty.
• B-One Ortho Mobio™ Revision Knee Augments and Stem Extensions Cleared: B-One Ortho, Corp. received FDA 510(k) clearance (K262341) for its b-ONE® Mobio™ Total Knee System revision cemented tibial augments, stem extensions, and press-fit stem extensions.

DAILY ANNOUNCEMENTS BY CATEGORY

Surgical Robotics, AI & Navigation

OrthAlign, Inc. — OrthAlign Surpasses 500,000 Joint Replacement Procedures Worldwide

• Summary: OrthAlign, Inc. announced that its handheld surgical navigation technology has been utilized in more than 500,000 joint replacement procedures globally across more than twenty countries. The milestone underscores rapid adoption across hospital and ambulatory surgery center (ASC) settings for total knee, total hip, partial knee, and revision knee arthroplasty, establishing open-platform handheld navigation as an accurate, cost-effective alternative to capital-intensive robotic systems.
• Key Details:
  • Device/System Name: Lantern® Handheld Navigation System
  • Status: Commercial Clinical Milestone (>500,000 Procedures)
  • Clinical Significance: Validates the clinical efficacy and economic viability of open-platform, handheld computer-assisted navigation in both hospital ORs and ASCs, delivering precise component alignment and soft-tissue balancing without the large footprint, high disposable costs, or rigid vendor lock-in of robotic consoles.
• Original Source: OrthoSpineNews

Joint Reconstruction

Catalyst OrthoScience & Redefine Surgery — Catalyst OrthoScience Joins Redefine Surgery as Founding Partner in Shoulder Arthroplasty Intelligence

• Summary: Catalyst OrthoScience announced a strategic partnership with Redefine Surgery, becoming its founding partner in shoulder arthroplasty to build an integrated surgical intelligence ecosystem. Spanning preoperative 3D planning, intraoperative guidance, workflow optimization, and procedural analytics, the initiative targets up to four times greater procedural efficiency and ten times lower technology costs compared to traditional navigation and robotic consoles.
• Key Details:
  • Device/System Name: Catalyst Shoulder Arthroplasty Ecosystem & Redefine Surgical Intelligence
  • Status: Strategic Technology & Educational Partnership
  • Clinical Significance: Pioneers data-driven decision support across the full shoulder episode of care, connecting anatomic and reverse shoulder arthroplasty workflows with continuous machine-learning insights to streamline operative duration, enhance ASC scalability, and improve patient-reported functional outcomes.
• Original Source: OrthoSpineNews

Spine & Orthobiologics

SIGNUS USA — SIGNUS USA Marks American Debut with First U.S. Implantation of the COSY OCT Spine Fixation System

• Summary: SIGNUS USA announced the successful first U.S. clinical implantation of the COSY Cervicothoracic-Occipital Rod-Screw Spine Implant System, performed by Dr. Sebastian Koga, Chief of Neurosurgery at Berkshire Health Systems. The modern posterior occipito-cervico-thoracic (OCT) system features modular screw trajectories with up to 70 degrees of angulation, dedicated transition rods for the cervicothoracic junction, and seamless integration with the established DIPLOMAT thoracolumbar system.
• Key Details:
  • Device/System Name: COSY Cervicothoracic-Occipital Rod-Screw Spine Implant System & DIPLOMAT® Integration
  • Status: First U.S. Clinical Implantation / Commercial Debut
  • Clinical Significance: Equips spine surgeons with versatile posterior OCT fixation accommodating lateral mass, pedicle, C2 pars, and translaminar screw paths within a single construct, while low-profile cannulated heads and cervicothoracic transition rods facilitate tissue-preserving, navigated techniques across complex occipitocervical and cervicothoracic deformities.
• Original Source: OrthoSpineNews

RECENTLY INDEXED FDA 510(k) & PMA CLEARANCES — ORTHOPAEDIC

Note: The openFDA database typically indexes clearances 2–4 weeks after the official decision date. Dates shown reflect the FDA decision date, not the indexing date.